Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Erica Love"'
Autor:
João Enxuto, Erica Love
Publikováno v:
Finance and Society, Vol 2 (2016)
João Enxuto and Erica Love are artists and writers living in New York City. Their writing has appeared in Art in America, Mousse Contemporary Art Magazine, Wired, and X-TRA Contemporary Art Quarterly. They have given talks and exhibited work at the
Externí odkaz:
https://doaj.org/article/c98b7b3fef70468a982a61efbd018ad4
Autor:
Gianna Kroening, Christy Spalink, Janice M. Mehnert, Ankeeta Joshi, Amin Yakubov, Arjun Vasant Balar, Deirdre Jill Cohen, Maher Abdul-Hay, Erica Love, Jennifer Wu, Joseph Ravenell, Kathie-Ann Joseph
Publikováno v:
JCO Oncology Practice. 18:e620-e625
PURPOSE: The recruitment of underserved patients into therapeutic oncology trials is imperative. The National Institutes of Health mandates the inclusion of minorities in clinical research, although their participation remains under-represented. Inst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1e5f793ead3505ca2b42aa70624024
https://doi.org/10.1200/op.21.00629
https://doi.org/10.1200/op.21.00629
Autor:
Joseph Ravenell, Christy Spalink, Gianna Kroening, Amin Yakubov, Kathie-Ann Joseph, Mohammad Maher Abdul Hay, Arjun Vasant Balar, Deirdre Jill Cohen, Erica Love, Jennifer Wu, Ankeeta Joshi, Janice M. Mehnert
Publikováno v:
Journal of Clinical Oncology. 39:1577-1577
1577 Background: Recruiting underserved patients onto therapeutic oncology trials is imperative in light of cancer disparities. Many institutions have increased enrollment with data mining tools that match patients to clinical trials, but such expens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::918141d31d712d8401487e274a1d7543
https://doi.org/10.1200/jco.2021.39.15_suppl.1577
https://doi.org/10.1200/jco.2021.39.15_suppl.1577
Publikováno v:
American Journal of Hypertension. 24:518-529
BACKGROUND Despite improved hypertension (HTN) awareness and treatment, racial disparities in HTN prevalence persist. An understanding of the biopsychosocial determinants of HTN is necessary to address racial disparities in the prevalence of HTN. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b80aed96fc569366e99aaff1ad4c147
https://doi.org/10.1038/ajh.2011.9
https://doi.org/10.1038/ajh.2011.9
Autor:
Erica Love, João Enxuto
Publikováno v:
Finance and Society, Vol 2, Iss 2, Pp 173-74 (2016)
Finance and Society, Vol 2, Iss 2, Pp /A-/A (2016)
Finance and Society, Vol 2, Iss 2, Pp /A-/A (2016)
The Institute for Southern Contemporary Art (ISCA) was founded in 2016 to advance a meaningful alternative to the problem of contemporary art production and its political economy. While technology is intensifying the soft power of speculation, reputa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c234788fb729a0eca17966e36381ec14
https://doi.org/10.2218/finsoc.v2i2.1730
https://doi.org/10.2218/finsoc.v2i2.1730
Publikováno v:
GEOPHYSICS. 70:B73-B81
The Kettle Creek watershed contains 50–100-year-old surface and underground coal mines that are a continuing source of acid mine drainage (AMD). To characterize the mining-altered hydrology of this watershed, an airborne reconnaissance was conducte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e20cf8636e9995ee032ce17f63b22555
https://doi.org/10.1190/1.2127110
https://doi.org/10.1190/1.2127110
Autor:
Steven J. Nicol, Michelle Yaw, Howard S. Hochster, Benjamin Levinson, Yuan Yuan, Deirdre Jill Cohen, Erica Love
Publikováno v:
Cancer chemotherapy and pharmacology. 68(2)
To determine the maximum tolerated dose (MTD) and the recommended phase II dose and to identify the dose-limiting toxicities (DLTs) of gemcitabine, administered by fixed-dose rate (FDR) infusion, combined with the antifolate agent pemetrexed in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43573123b560c9580799b8cd2b18a0ab
https://pubmed.ncbi.nlm.nih.gov/20978761
https://pubmed.ncbi.nlm.nih.gov/20978761
Autor:
Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole L. Kallewaard, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney A. Cohen, John M. Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet Menachery, Kumari Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart
Publikováno v:
Cell Reports, Vol 39, Iss 7, Pp 110812- (2022)
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibodies (mAbs) can reduce the risk of hospitalization from coronavirus disease 2019 (COVID-19) when administered early. However, SARS-CoV-2 variants of c
Externí odkaz:
https://doaj.org/article/daeff3ff2f814504a3643f35bb419fcf
Autor:
Deirdre Jill Cohen, Naoko Takebe, James L. Wade, Michael K. Gibson, Susan G. Urba, Peter Kozuch, Paul J. Christos, Yelena Y. Janjigian, Sanaa Tahiri, Daniel Virgil Thomas Catenacci, Lakshmi Rajdev, Hedy L. Kindler, Katherine Vandris, Howard S. Hochster, T. Bekaii-Saab, Emily Chan, Erica Love, Joseph A. Sparano
Publikováno v:
Journal of Clinical Oncology. 31:4011-4011
4011 Background: The HH pathway is overexpressed in gastroesophageal (GE) tumors. Pre-clinically, HH inhibitors have demonstrated a reduction in GE tumor growth, cell motility and invasiveness. V, an oral small-molecule antagonist of the Hh pathway,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57ca3c380cd2aa2372032386b29997a0
https://doi.org/10.1200/jco.2013.31.15_suppl.4011
https://doi.org/10.1200/jco.2013.31.15_suppl.4011
Autor:
Katherine Vandris, Susan G. Urba, Deirdre Jill Cohen, Naoko Takebe, James L. Wade, Paul J. Christos, Peter Kozuch, Lakshmi Rajdev, Sanaa Tahiri, Michael K. Gibson, Joseph A. Sparano, Hedy L. Kindler, Yelena Y. Janjigian, Daniel Virgil Thomas Catenacci, T. Bekaii-Saab, Emily Chan, Howard S. Hochster, Erica Love
Publikováno v:
Journal of Clinical Oncology. 31:67-67
67 Background: The HH pathway is overexpressed in gastroesophageal (GE) tumors. Pre-clinically, HH inhibitors have demonstrated a reduction in GE tumor growth, cell motility and invasiveness. V, an oral small-molecule antagonist of the Hh pathway, ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fef3f1bb68710f1b5f1c668dd1986b0
https://doi.org/10.1200/jco.2013.31.4_suppl.67
https://doi.org/10.1200/jco.2013.31.4_suppl.67